Adrian Ruskin Email

Director Operations . Avacta

Current Roles

Employees:
303
Revenue:
$47M
About
Custom antibody alternative, Antibody alternatives, Afinnity reagents Avacta has developed Affimer technology - a revolutionary new engineered affinity protein that is an alternative to antibodies. Affimer molecules have been developed for applications in diagnostics, drug / biomarker discovery, biotech research and development and therapeutics. Find out more on our website.
Avacta Address
Thorp Arch Estate
, null
UK

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.